Current role of dexmedetomidine in clinical anesthesia and intensive care | Zendy

Manpreet Kaur | Zendy; Preet Mohinder Singh | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Current role of dexmedetomidine in clinical anesthesia and intensive care

Author(s) -

Manpreet Kaur,

Preet Mohinder Singh

Publication year - 2011

Publication title -

anesthesia essays and researches

Language(s) - English

Resource type - Journals

ISSN - 0259-1162

DOI - 10.4103/0259-1162.94750

Subject(s) - dexmedetomidine , medicine , sedation , sedative , anesthesia , delirium , perioperative , agonist , intensive care , medetomidine , analgesic , intensive care medicine , receptor , blood pressure , heart rate

Dexmedetomidine is a new generation highly selective α2-adrenergic receptor (α2-AR) agonist that is associated with sedative and analgesic sparing effects, reduced delirium and agitation, perioperative sympatholysis, cardiovascular stabilizing effects, and preservation of respiratory function. The aim of this review is to present the most recent topics regarding the advantages in using dexmedetomidine in clinical anesthesia and intensive care, while discussing the controversial issues of its harmful effects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research